Trademark Overview
On Friday, December 6, 2024, a trademark application was filed for SOLVONIS with the United States Patent and Trademark Office. The USPTO has given the SOLVONIS trademark a serial number of 79422293. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 24, 2025. This trademark is owned by Graft Polymer (UK) Plc. The SOLVONIS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals and medical preparations; pharmaceuticals and medical preparations for the treatment of behavioural health disorders, mental health disorders and addiction.
Chemicals and chemical substances for use in industry, in science and in the manufacture of pharmaceuticals; biological and biochemical substances for use in industry, in science and in the manufacture of pharmaceuticals.
Medical services; pharmaceutical services; therapy services; telehealth services; mental health services; medical counselling services; psychological counselling services; psychotherapy services; health counselling services; behavioural health counselling services; design and provision of behavioural health treatment programmes; addiction counselling and treatment services; administration, advisory, analysis, assessment, assistance, consultancy, evaluation, information and testing services in the fields of therapy, of telehealth, of mental health, of medical counselling, of psychology, of psychotherapy, of health counselling, of behavioural health counselling, of behavioural health, of behaviour and of addiction (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); advisory, consultancy and information services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics.
Scientific services; clinical research services; administration, advisory, analysis, assessment, assistance, auditing, consultancy, design, development, due diligence, evaluation, information, inspection, research and testing services in the fields of chemicals, of chemical substances, of biological substances, of biochemical substances, of science, of clinical research, of artificial intelligence, of machine learning and of biotechnology (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); administration, analysis, assessment, assistance, auditing, design, development, due diligence, evaluation, inspection, research and testing services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); auditing, design, development, due diligence, inspection and research services in the fields...
